Longevity Supplement Research Library

Spermidine & Autophagy

Human spermidine research is still developing. A 2022 randomized trial in older adults with subjective cognitive decline did not support turning spermidine into a broad cognitive-treatment claim, while a 2025 pilot study of 3.3 mg/day spermidine-rich rice germ extract reported exploratory changes in autophagy-related and cardiometabolic biomarkers. Mechanism is interesting; certainty is not the same thing.

• SmartAge randomized trial
• Spermidine-rich rice germ pilot study
• SmartAge pilot trial

NAD+ & NMN

NMN is a precursor in NAD+ metabolism. Human randomized trials have shown that oral NMN can raise blood NAD-related measures, but effects on clinical outcomes are mixed and study-specific. A 2024 review of randomized trials found the metabolic-benefit picture remained uncertain, which is a useful antidote to labels that behave as if NAD+ biology already settled every longevity question.

• NMN randomized dose-ranging trial
• NMN 12-week older-adult trial
• NMN randomized-trial metabolic review

Resveratrol & Quercetin

Resveratrol and quercetin are polyphenols with substantial preclinical and human research, but outcomes vary by dose, population and endpoint. A 2025 meta-analysis found no significant overall effect of resveratrol supplementation on human SIRT1 in the pooled analysis, while human quercetin studies show that bioavailability differs substantially across formulations.

• Resveratrol and human SIRT1 meta-analysis
• Quercetin bioavailability systematic review
• Quercetin randomized crossover trial

Longevity Stacks

A longevity stack combines ingredients with different biological rationales. That can make a formula coherent, but separate ingredient studies do not prove the finished combination is clinically synergistic. The more complicated the stack, the more important transparent doses and finished-product evidence become.

• NMN randomized dose-ranging trial
• Spermidine randomized trial
• Resveratrol and SIRT1 meta-analysis

Why primary research matters

Primary studies and high-quality systematic reviews are more useful than repeating claims across dozens of supplement blogs. The research library exists to show the evidentiary backbone behind the buyer guides.

How studies are selected

Priority goes to human randomized trials, systematic reviews, meta-analyses, and well-designed human observational work when the question requires it. Mechanistic and preclinical research can explain plausibility but is not used as a substitute for human outcomes.

How we interpret trials

A trial is read in context: participant characteristics, sample size, dose, duration, comparator, primary outcome, secondary outcomes, adverse events, and funding all influence what can reasonably be concluded.

Ingredient evidence versus product evidence

A finished commercial product should not automatically inherit all evidence on a named ingredient. Product-specific formulation, dose, purity, co-ingredients, and delivery system can matter.

Negative and null findings

Null results are evidence too. A useful research library does not hide studies simply because they make a marketing story less exciting.

Updates

New trials can change the strength of a conclusion. Research pages and product comparisons should therefore be revisable instead of presenting publication as the end of the analysis.

Conflicts and funding

Industry funding does not automatically invalidate a study, but it is relevant context. Study design and reporting quality matter more than treating funding source as a shortcut for acceptance or dismissal.

Reader use

Readers should use the research library to understand what is known, what is uncertain, and where commercial claims extend beyond the available human evidence.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.

Decision framework for Longevity Supplement Research Library

For Longevity Supplement Research Library, the final decision should combine product transparency, evidence quality, dose clarity, current price, practical serving structure, and personal suitability. No single field is strong enough to carry the entire recommendation. A transparent product can still have limited efficacy evidence, and a well-studied ingredient can still appear in a poorly disclosed commercial formula. The useful approach is to keep those judgments separate and update them when the evidence or product changes.